Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

Autor: de Jong, Marion, Valkema, Roelf, Jamar, Francois, Kvols, Larry K., Kwekkeboom, Dik J., Breeman, Wout A.P., Bakker, Willem H., Smith, Chuck, Pauwels, Stanislas, Krenning, Eric P.

Publikováno v: In Seminars in Nuclear Medicine 2002 32(2):133-140

[[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate: comparison with [[sup 111] In-DTPA[sup 0] ]octreotide in patients.

Autor: Kwekkeboom, Dik J., Bakker, Willem H., Kooij, Peter P. M., Konijnenberg, Mark W., Srinivasan, Ananth, Erion, Jack L., Schmidt, Michelle A., Bugaj, Joe L., de Jong, Marion, Krenning, Eric P.

Publikováno v: European Journal of Nuclear Medicine. 2001, Vol. 28 Issue 9, p1319. 7p.

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA[sup 0] ,d-Phe[sup 1] ,Tyr[sup 3] ]octreotide, a promising somatostatin analogue for radionuclide therapy.

Autor: de Jong, Marion, Bakker, Willem H., Krenning, Eric P., Breeman, Wout A. P., van der Pluijm, Marcel E., Bernard, Bert F., Visser, Theo J., Jermann, Eduard, Béhé, Martin, Powell, Pia, Mäcke, Helmut R.

Publikováno v: European Journal of Nuclear Medicine. 1997, Vol. 24 Issue 4, p368. 4p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bone marrow dosimetry in peptide receptor radionuclide therapy with [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate.

Autor: Forrer, Flavio, Krenning, Eric P., Kooij, Peter P., Bernard, Bert F., Konijnenberg, Mark, Bakker, Willem H., Teunissen, Jaap J. M., de Jong, Marion, van Lom, Kirsten, de Herder, Wouter W., Kwekkeboom, Dik J.

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging; Jul2009, Vol. 36 Issue 7, p1138-1146, 9p, 1 Color Photograph, 1 Black and White Photograph, 1 Chart, 3 Graphs